Gameto

Gameto company information, Employees & Contact Information

Explore related pages

Related company profiles:

Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives. Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. We aim to change that. Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, we have developed a platform to produce female reproductive cell lines. We use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Our team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Our first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno.

Company Details

Employees
49
Founded
-
Address
New York, New York, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
New York, New York
Looking for a particular Gameto employee's phone or email?

Gameto Questions

News

Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo Study - Business Wire

Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo Study Business Wire

Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference Yahoo Finance

Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments - PR Newswire

Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments PR Newswire

Cerebras and Titan's big raise, and a gold miner seeks to IPO - Axios

Cerebras and Titan's big raise, and a gold miner seeks to IPO Axios

Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit - citybiz

Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit citybiz

Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body - Yahoo Finance

Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body Yahoo Finance

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells - PR Newswire

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells PR Newswire

Gameto Announces Landmark Pregnancy Rate for iPSC-Derived Fertilo, Achieving More Than Double the Success Rate of Standard IVM - Business Wire

Gameto Announces Landmark Pregnancy Rate for iPSC-Derived Fertilo, Achieving More Than Double the Success Rate of Standard IVM Business Wire

Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials - Business Wire

Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials Business Wire

Top Gameto Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant